The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 90 results:
Author Title Type [ Year(Asc)]
Filters: Author is Karvounis, Haralambos  [Clear All Filters]
2020
Gatzoulis, K. A., Dilaveris P., Arsenos P., Tsiachris D., Antoniou C-K., Sideris S., et al. (2020).  Arrhythmic risk stratification in nonischemic dilated cardiomyopathy: The ReCONSIDER study design - A two-step, multifactorial, electrophysiology-inclusive approach.. Hellenic J Cardiol.
Vlachou, M., Kamperidis V., Giannakoulas G., Karamitsos T., Vlachaki E., & Karvounis H. (2020).  Biochemical and imaging markers in patients with thalassaemia.. Hellenic J Cardiol.
Repanas, T. I., Papanastasiou C. A., Efthimiadis G. K., Fragkakis N., Sachpekidis V., Klein R. Michael, et al. (2020).  Cardiovascular magnetic resonance as a complementary method to transthoracic echocardiography for aortic valve area estimation in patients with aortic stenosis: A systematic review and meta-analysis.. Hellenic J Cardiol.
Mouratoglou, S. Anastasia, Kallifatidis A., Pitsiou G., Grosomanidis V., Kamperidis V., Chalikias G., et al. (2020).  Duration of interventricular septal shift toward the left ventricle is associated with poor clinical outcome in precapillary pulmonary hypertension: A cardiac magnetic resonance study.. Hellenic J Cardiol. 61(2), 112-117.
Adamopoulos, S., Miliopoulos D., Karavidas A., Nikolaou M., Lazaros G., Gkouziouta A., et al. (2020).  HEllenic Registry on Myocarditis SyndromES on behalf of Hellenic Heart Failure Association: The HERMES-HF Registry.. ESC Heart Fail.
Ntiloudi, D., Dimopoulos K., Tzifa A., Karvounis H., & Giannakoulas G. (2020).  Hospitalizations in adult patients with congenital heart disease: an emerging challenge.. Heart Fail Rev.
Arvanitaki, A., Michou E., Kalogeropoulos A., Karvounis H., & Giannakoulas G. (2020).  Mildly symptomatic heart failure with reduced ejection fraction: diagnostic and therapeutic considerations.. ESC Heart Fail. 7(4), 1477-1487.
Karamitsos, T. D., Arvanitaki A., Karvounis H., Neubauer S., & Ferreira V. M. (2020).  Myocardial Tissue Characterization and Fibrosis by Imaging.. JACC Cardiovasc Imaging. 13(5), 1221-1234.
Doundoulakis, I., Antza C., Karvounis H., & Giannakoulas G. (2020).  Non-Vitamin K Antagonist Oral Anticoagulants in Pulmonary Embolism: An Overview of Systematic Reviews.. Curr Pharm Des. 26(23), 2686-2691.
Stalikas, N., Doundoulakis I., Karagiannidis E., Bouras E., Kartas A., Frogoudaki A., et al. (2020).  Non-Vitamin K Oral Anticoagulants in Adults with Congenital Heart Disease: A Systematic Review. J Clin Med. 9(6), 
Efthimiadis, G., Zegkos T., Meditskou S., Karamitsos T., Manolakos E., Papoulidis I., et al. (2020).  A novel desmoplakin mutation associated with left dominant arrhythmogenic cardiomyopathy and cutaneous phenotype.. Hellenic J Cardiol.
Arvanitaki, A., Giannakoulas G., Triantafyllidou E., Karvounis H., & Dimitroulas T. (2020).  Peripheral Microangiopathy in Patients with Precapillary Pulmonary Hypertension: Correlation with Cardiac Function and Patients' Functional Capacity. Study Design and Rationale.. Mediterr J Rheumatol. 31(3), 369-373.
Arvanitaki, A., Mouratoglou S. Anastasia, Evangeliou A., Grosomanidis V., Hadjimiltiades S., Skoura L., et al. (2020).  Quality of Life is Related to Haemodynamics in Precapillary Pulmonary Hypertension.. Heart Lung Circ. 29(1), 142-148.
Kartas, A., Doundoulakis I., Ntiloudi D., Koutsakis A., Kosmidis D., Rampidis G., et al. (2020).  Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study.. BMJ Open. 10(9), e038012.
Zafeiropoulos, S., Farmakis I., Kartas A., Arvanitaki A., Pagiantza A., Boulmpou A., et al. (2020).  Risk for Recurrent Cardiovascular Events and Expected Risk Reduction With Optimal Treatment 1 Year After an Acute Coronary Syndrome.. Am J Cardiol. 133, 7-14.
Mouratoglou, S. Anastasia, Patsiala A., Feloukidis C., Karvounis H., & Giannakoulas G. (2020).  Transition protocol from subcutaneous treprostinil to intravenous epoprostenol in deteriorating patients with pulmonary arterial hypertension.. Int J Cardiol. 306, 187-189.
2019
Ntusi, N. A. B., Francis J. M., Gumedze F., Karvounis H., Matthews P. M., Wordsworth P. B., et al. (2019).  Cardiovascular magnetic resonance characterization of myocardial and vascular function in rheumatoid arthritis patients.. Hellenic J Cardiol. 60(1), 28-35.
Arvanitaki, A., Boutsikou M., Anthi A., Apostolopoulou S., Avgeropoulou A., Demerouti E., et al. (2019).  Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE).. Pulm Circ. 9(3), 2045894019877157.
Kartas, A., Samaras A., Vasdeki D., Dividis G., Fotos G., Paschou E., et al. (2019).  Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge.. J Cardiovasc Pharmacol Ther. 24(3), 225-232.
Ntiloudi, D., Apostolopoulou S., Vasiliadis K., Frogoudaki A., Tzifa A., Ntellos C., et al. (2019).  Hospitalisations for heart failure predict mortality in pulmonary hypertension related to congenital heart disease.. Heart. 105(6), 465-469.
Kartas, A., Samaras A., Vasdeki D., Dividis G., Fotos G., Paschou E., et al. (2019).  Hospitalization affects the anticoagulation patterns of patients with atrial fibrillation.. J Thromb Thrombolysis. 48(2), 225-232.
Ntiloudi, D., Zanos S., Gatzoulis M. A., Karvounis H., & Giannakoulas G. (2019).  How to evaluate patients with congenital heart disease-related pulmonary arterial hypertension.. Expert Rev Cardiovasc Ther. 17(1), 11-18.
Ntelios, D., Karamitsos T. D., Boufidou A., Thisiadou K., & Karvounis H. (2019).  Inconsistent high sensitivity troponin T and I measurements in a patient with rheumatoid arthritis.. Hellenic J Cardiol. 60(1), 59-60.
Farmakis, I., Zafeiropoulos S., Pagiantza A., Boulmpou A., Arvanitaki A., Tampaki A., et al. (2019).  Low-density lipoprotein cholesterol target value attainment based on 2019 ESC/EAS guidelines and lipid-lowering therapy titration for patients with acute coronary syndrome.. Eur J Prev Cardiol. 2047487319891780.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.